STAAR Reports 6 Percent Increase in Net Sales in Q1-2017

May 12, 2017: By Jon Swedien

STAARSTAAR Surgical had net sales of $20.4 million in Q1-2017, a 6 percent increase over its Q1-2016 net sales, the company reported May 3.

Net sales of STAAR’s Visian Implantable Collamer Lens (ICL) were up 16 percent for Q1-2017 compared with the same quarter in 2016, according to the Monrovia, California, company.

The number of ICLs units sold was up 20 percent for Q1-2017 compared with Q1-2016.

STAAR’s sales for ICLs grew 65 percent in Canada, 65 percent in Japan, and 45 percent in China in Q1-2017 compared with Q1-2016, the company said.

The company’s IOL sales were down 9 percent in Q1-2017 compared with Q1-2016, while the number of units sold was flat. Injector parts dropped 54 percent.

STAAR said it anticipates flat to declining growth for IOL sales in 2017 with the discontinuation of its US silicone IOL business.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

FDA Ophthalmic Devices Panel to hold Meeting Oct. 27

Novartis’ RTH258 Successful in Two Phase III Studies for nAMD

Ocugen Closes $7.5 Million Series B Round

Genentech Uses Vital Art and Science Vision-Testing App in Phase II Study of Sustained Delivery of Lucentis

US Supreme Court Ruling Shortens Time to Market for Biosimilars

Ellex Acquires Royalty Commitment for iTrack Device for $2.15 Million

Johnson & Johnson Vision Names Jonathan Talamo, MD, Chief Medical Officer

Teva Launches Generic Versions of Pataday in US

David Karcher Stepping Down as Executive Director, CEO of ASCRS

EyeGate Raises $10 Million in Public Offering

Aerie Raises $125 Million through Upsized Public Offering, ATM Program

pSivida’s Durasert for Posterior Segment Uveitis Successful in Second Phase III Study

Mynosys Zepto Receives US FDA 510(k) Clearance

Ozurdex, Humira Gain NICE Backing for Non-infectious Posterior Uveitis

Roger Steinert, Pioneer in Ophthalmology, Dies at 66

Carl Zeiss Meditec to Build New Innovation Center in Northern California

Gottlieb Says FDA to Publish List of Drugs Without Generic Competition

REGENXBIO Announces Phase I Clinical Trial for RGX-314 Gene Therapy for Wet AMD

Belkin Laser Closes Nearly $5 Million Financing Round

Valeant in Talks to Sell Surgical Business to Carl Zeiss Meditec

Coming soon

2017 Cataract Surgical Equipment: A Global Market Analysis for 2016 to 2022